Literature DB >> 16137882

Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.

Mustafa Toprakçí1, Kemal Yelekçi.   

Abstract

Monoamine oxidase (EC1.4.3.4; MAO) is a mitochondrial outer membrane flavoenzyme that catalyzes the oxidation of biogenic amines. It has two distinct isozymic forms designated MAO-A and MAO-B, each displaying different substrate and inhibitor specificities. They are the well-known targets for antidepressant and neuroprotective drugs. Elucidation of the X-ray crystallographic structure of MAO-B has opened the way for molecular modeling studies. A series of experimentally tested (1-10) model compounds has been docked computationally to the active site of the MAO-B enzyme. The AutoDock 3.0.5 program was employed to perform automated molecular docking. The free energies of binding (DeltaG) and inhibition constants (K(i)) of the docked compounds were calculated by the Lamarckian Genetic Algorithm (LGA) of AutoDock 3.0.5. Excellent to good correlations between the calculated and experimental K(i) values were obtained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137882     DOI: 10.1016/j.bmcl.2005.07.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.

Authors:  Tuane Bazanella Sampaio; Juliana Trevisan Da Rocha; Marina Prigol; Rogério Aquino Saraiva; Pablo Froner Nogara; André Luiz Agnes Stein; João Batista Teixeira da Rocha; Gilson Zeni; Cristina Wayne Nogueira
Journal:  J Mol Neurosci       Date:  2016-04-06       Impact factor: 3.444

2.  Insights into the binding mode of new N-substituted pyrazoline derivatives to MAO-A: docking and quantum chemical calculations.

Authors:  Safiye Sağ Erdem; Seyhan Türkkan; Kemal Yelekçi; Nesrin Gökhan-Kelekçi
Journal:  J Neural Transm (Vienna)       Date:  2012-12-16       Impact factor: 3.575

3.  Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.

Authors:  K Yelekçi; O Karahan; M Toprakçi
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

4.  In silico identification of novel and selective monoamine oxidase B inhibitors.

Authors:  Kemal Yelekçi; Bora Büyüktürk; Nurdan Kayrak
Journal:  J Neural Transm (Vienna)       Date:  2012-12-15       Impact factor: 3.575

5.  Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies.

Authors:  Angélica Fierro; Mauricio Osorio-Olivares; Bruce K Cassels; Dale E Edmondson; Silvia Sepúlveda-Boza; Miguel Reyes-Parada
Journal:  Bioorg Med Chem       Date:  2007-05-22       Impact factor: 3.641

6.  Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b.

Authors:  Trevor G Marshall; Robert E Lee; Frances E Marshall
Journal:  Theor Biol Med Model       Date:  2006-01-10       Impact factor: 2.432

7.  3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Priyanka Dhiman; Neelam Malik; Anurag Khatkar
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, in vitro bioevaluation and molecular docking studies.

Authors:  Syed Mobasher Ali Abid; Sana Aslam; Sumera Zaib; Syeda Mahwish Bakht; Matloob Ahmad; Muhammad Makshoof Athar; John M Gardiner; Jamshed Iqbal
Journal:  Medchemcomm       Date:  2017-01-03       Impact factor: 3.597

9.  Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.

Authors:  Begüm Nurpelin Sağlık; Betül Kaya Çavuşoğlu; Ulviye Acar Çevik; Derya Osmaniye; Serkan Levent; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  RSC Med Chem       Date:  2020-08-18

10.  Molecular interaction of Survivin and Piperine by computational docking analyses for neuroblastoma targeting.

Authors:  V Muthukumar; A J Vanisree
Journal:  Ann Neurosci       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.